"On-Demand Webinar" How to find the next 10x stock - Investing in great Canadian & U.S. Small-Caps

If you attended our Fall 2022 Live Webinar, you would have received our BUY recommendation on Hammond Power (HPS.A:TSX), a completely unknown Canadian Electrification stock that jumped from $16 to $115.00 today, making it the best performing revenue producing Stock on the TSX over the past year – sign-up for our Live 2024 Webinar and receive our top 5-6 stocks to buy today – do not miss out!

In the Fall of 2022, Hammond Power was set to more than double its earnings. But no other analyst in the country was recommending the stock.

In fact, it remains completely off the radar of Big Bank advisors, despite being a top performer in Canada over the past 2 decades.

20-months later Hammond Power has surged 627.40% to the $115.00 range driven by record earnings growth. The company continues to benefit from the surge in EV ownership and the aging North American electrical grid – both of which are potential generational opportunities.

For our clients, the story of this great stock began back in early 2000s, when Hammond Power traded for just pennies, in the $0.60 range – our original BUY recommendation. Hammond Power was a profitable, growing business purchased for under $1.00 – with no analyst coverage.  The stock has now gained 19,887%.

Just $25,000 invested in the stock back then would be worth over $5.08 million today.  Truly a portfolio changing investment.

But it does not stop at Hammond Power, KeyStone’s research team has also recommended the best performing stock in all of Canada over the past decade, the Boyd Group (BYD:TSX), up over 9,900%.

For clients, our initial Focus BUY recommendation following the 2023 Live Webinars was Cipher Pharmaceuticals (CPH:TSX).

Quick Update:

Cipher Pharmaceuticals (CPH:TSX)

Recommended: August 28, 2023, at $3.89

Today’s Price: $13.81

Gain: 255.01%

Cipher (CPH:TSX) is a unique specialty pharmaceutical Small-Cap Stock that is profitable, growing organically & via acquisitions, with a strong cash rich (originally 45%+ of its value in cash & no debt) balance sheet. The stock recently made a transformational acquisition and continues to report solid financial results driving it to new highs. Cipher is a recent excellent example of how research can produce strong gains for clients.

KeyStone’s second Small-Cap BUY recommendation to clients following our 2023 Webinars, was VitalHub (VHI:TSX), a small-cap Canadian healthcare software company, at a price of $3.24. We had followed VitalHub and interviewed management for years, but were monitoring the stock for an attractive entry point. Just 9 months after our initial recommendation the stock is up 158.95% to $8.39, driven by strong cash flow generation, a significant acquisition and a cash rich balance sheet.

Attend our upcoming Live Webinar:

• Learn how to stop missing out on these game changing stocks that you do not hear about from your traditional Big Bank advisor.
• How the construction of your stock portfolio may be preventing you from creating true wealth through great growth stocks and how you can make simple changes today to correct this.
• How adding just 2-3 great stocks in your lifetime (like Hammond Power) can dramatically affect your wealth long-term.

Attend our Live no-nonsense Stock Investing Webinar with real world examples, well researched stock recommendations (5-6 you can start buying today), receive the first ever BUY Report from our New U.S. Small-Cap Research Service and VIP Ticket holders receive three additional bonusses; 1) KeyStone’s Fall 2023 U.S. Mid-Cap Growth Stock BUY Report ($599), 2) 2024 Fall Canadian REIT Special Report ($599), & 3) On-Demand DIY Stock Investing Webinar – “Simplify Your Stock Portfolio in 2024 – Buy 15-25 Great Businesses” ($79.00) – let us help you become a better investor.

If you need further proof that our research and live Webinars are worth your time, have a listen to several of the thousands of Canadian investors who have attended one of our Stock Investing Webinars. In other words, don’t just take my word for it.

KeyStone’s top analysts Ryan Irvine, Aaron Dunn, Brennan Habetler, & Brett Rodway will detail 5-6 Small-Cap Buy Recommendations from both our Canadian Small-Cap and New U.S. growth stocks services. The same analysts picked both the best performing stock over the past 2, 3, and 5-years as well as the past decade on the Toronto Stock Exchange.

Join the thousands of Canadians who have already benefited from KeyStone’s no-nonsense stock portfolio-building seminars. Purchase our On-Demand Webinar we will also give you 5-6 top growth & dividend growth stocks you can buy today including:

1. 1. Top Unknown Canadian Gold stock – trading at 8times earnings with a growing 2.9% dividend and significant expansion plans -giving the stock 3-4 times return potential.
   2. A Cash-Rich Canadian Software Consolidator with $250 million in cash, generating $90 million in annual cash flow to grow via acquisition.
   3. Unknown Cash-Rich U.S. Electrification Small-Cap at 12 times EPS with strong growth guidance for 2024 and into 2025.
   4. Top Canadian Small-Cap Digital Bank trading at 9 times earnings with a 10x growth opportunity.
   5. 2 Top unknown cash-rich small-cap –searching for the next Hammond Power, Boyd, XPEL, WaterFurnace, or Photon Control – stocks that were recommended by no other analyst in Canada, but could have changed your portfolio if bought on KeyStone’s recommendation.
   6. As a bonus we will detail BUY recommendation in our Newly Launched U.S. Small-Cap Research Service.  
   7. And more..

 “Investing in just 2 or 3 truly great stocks in your lifetime can be game changing for your portfolio.”

This past year Warren Buffett, perhaps the greatest investor of all time, stated that “In his 58 years of Berkshire management (his) satisfactory results have been the product of about a dozen truly good decisions – that would be about one every five years.”

Let that sink in. Only 12 great investments (stocks) in his almost hundred years on earth, have made him one of the richest humans on the planet.

Truly great stocks create truly great wealth. It’s that simple. Unfortunately, if you construct your portfolio with the traditional Big Bank approach, buying 5-20 mutual funds and ETFs which each own 100+ stocks, you cannot take advantage of these great stocks. A portfolio built in this manner owns 500 to 1000s of stocks and will mirror the market (because it is the market) but underperform due to the high fees. There is a better way. 

Focussed Diversification – the better way to build a portfolio.

Let KeyStone help you build a simple 20-25 stock portfolio designed to save on fees and position you to benefit from great capital compounding stocks.

Use our research to fill these three core areas in your portfolio with 20-25 stocks over a 24-month period.

Whether you are looking for Canadian growth, dividend/income, exposure to U.S. growth & technology leaders, or a portfolio including all of the above, find our how one of our research services can work for you.

Free for All Attendees

1. The first ever BUY Report from our New U.S. Small-Cap Research Service – cash rich, U.S. small-cap with over 100% earnings growth, trading at 12 times EPS.
2. KeyStone’s 2024 Canadian REIT Special Report ($599) – Analysis and top recommendation from the universe of Canadian REITs.
3. KeyStone’s Fall 2024 U.S. Mid-Cap Growth Stock BUY Report ($599) – [Coming Soon] – Analysis and top recommendations of U.S. Mid-Cap companies with market caps between $2-to-$25 Billion.
4. On-Demand Webinar: “Simplify Your Stock Portfolio in 2024 – Buy 15-25 Great Businesses” ($79).